临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
15期
23-24
,共2页
支气管肺炎%布地奈德%异丙托溴铵%治疗结果
支氣管肺炎%佈地奈德%異丙託溴銨%治療結果
지기관폐염%포지내덕%이병탁추안%치료결과
Bronchopneumonia%Budesonide%Ipratropium bromide%Treatment outcome
目的:探讨布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的临床疗效。方法选取2011-2013年本院收治的小儿支气管肺炎98例,随机分为观察组与对照组,各49例,对照组予以常规抗感染治疗,观察组在对照组的基础上予以布地奈德混悬液联合异丙托溴铵雾化吸入,比较两组疗效。结果观察组的治疗总有效率为95.92%,高于对照组的85.71%,差异有统计学意义(P <0.05);观察组的止咳时间、气喘缓解时间、肺部啰音消失时间及胸 X 线片阴影消失时间均较对照组缩短,差异有统计学意义(P <0.05)。结论布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效显著,并可缩短疗程,无明显不良反应。
目的:探討佈地奈德混懸液聯閤異丙託溴銨霧化治療小兒支氣管肺炎的臨床療效。方法選取2011-2013年本院收治的小兒支氣管肺炎98例,隨機分為觀察組與對照組,各49例,對照組予以常規抗感染治療,觀察組在對照組的基礎上予以佈地奈德混懸液聯閤異丙託溴銨霧化吸入,比較兩組療效。結果觀察組的治療總有效率為95.92%,高于對照組的85.71%,差異有統計學意義(P <0.05);觀察組的止咳時間、氣喘緩解時間、肺部啰音消失時間及胸 X 線片陰影消失時間均較對照組縮短,差異有統計學意義(P <0.05)。結論佈地奈德混懸液聯閤異丙託溴銨霧化治療小兒支氣管肺炎的療效顯著,併可縮短療程,無明顯不良反應。
목적:탐토포지내덕혼현액연합이병탁추안무화치료소인지기관폐염적림상료효。방법선취2011-2013년본원수치적소인지기관폐염98례,수궤분위관찰조여대조조,각49례,대조조여이상규항감염치료,관찰조재대조조적기출상여이포지내덕혼현액연합이병탁추안무화흡입,비교량조료효。결과관찰조적치료총유효솔위95.92%,고우대조조적85.71%,차이유통계학의의(P <0.05);관찰조적지해시간、기천완해시간、폐부라음소실시간급흉 X 선편음영소실시간균교대조조축단,차이유통계학의의(P <0.05)。결론포지내덕혼현액연합이병탁추안무화치료소인지기관폐염적료효현저,병가축단료정,무명현불량반응。
Objective To study the clinical efficacy of budesonide suspension combined with ipratropium bromide nebulizer in the treatment of children with bronchial pneumonia. Methods 98 cases of children with bronchial pneumonia in our hospital from 2011 to 2013,which were randomly divided into observation group and control group,49 cases in each group. The control group was given conventional anti - infection treatment,observation group was given budesonide suspension combined with ipratropium bromide nebulizer on the basis of the control group,the clinical efficacy of the two groups were compared. Re-sults The total effective rate of the observation group was 95. 92% ,which was higher than 85. 71% of control group,the difference was statistically significant(P < 0. 05);The cough time,asthma relief time,pulmonary rales disappeared time and chest X - ray shadow disappear time of observation group were shorter than control group,the differences were statistically signif-icant(P < 0. 05). Conclusion Budesonide suspension combined with ipratropium bromide nebulizer in the treatment of chil-dren with bronchial pneumonia has significant effect,and can shorten course of treatment,has no significant adverse reactions.